Works matching DE "CHRONIC myeloid leukemia"

Results: 5000

Penile juvenile xanthogranuloma and neurofibromatosis type-1: risk association with juvenile myelomonocytic leukaemia?

Published in:

2010

By:

AlGhamdi, K. M.;
Suwaidan, S. N. Al

Publication type:

Case Study

EUTOS Score Validated for Predicting Treatment Outcomes With TKI Therapy.

Published in:: Oncology (08909091), 2013, v. 27, n. 8, p. 814
Publication type:: Article

First-Line Treatment for Patients With CML in Chronic Phase: Second-Generation TKIs Are the Therapy of Choice.

Published in:

Oncology (08909091), 2013, v. 27, n. 8, p. 781

By:

CORTES, JORGE

Publication type:

Article

First-Line Treatment for Patients With CML in Chronic Phase: Why Imatinib Is an Appropriate Choice.

Published in:

Oncology (08909091), 2013, v. 27, n. 8, p. 780

By:

SCHIFFER, CHARLES A.

Publication type:

Article

Front-Line TKI Therapy for Chronic-Phase CML: the Luxury of Choice.

Published in:

2012

By:

Shah, Neil P.

Publication type:

Opinion

Which TKI Should Be Recommended as Initial Treatment for CML in Chronic Phase?

Published in:

2012

By:

Schiffer, Charles A.

Publication type:

Opinion

Is Imatinib Still an Acceptable First-Line Treatment for CML in Chronic Phase?

Published in:

Oncology (08909091), 2012, v. 26, n. 10, p. 901

By:

Goldman, John M.;
Marin, David

Publication type:

Article

Test Your Image IQ.

Published in:: Oncology (08909091), 2012, v. 26, n. 9, p. 819
Publication type:: Article

ASCO REPORTS: HIGHLIGHTS FROM EXCLUSIVE ONCOLOGY INTERVIEWS.

Published in:: 2012
Publication type:: Interview

Advances in Genetics and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders.

Published in:: 2009
Publication type:: Abstract

When Imatinib Fails.

Published in:

Oncology (08909091), 2008, v. 22, n. 4, p. 448

By:

Stone, Richard

Publication type:

Article

Second-Generation TKIs in Chronic Myelogenous Leukemia.

Published in:

Oncology (08909091), 2008, v. 22, n. 4, p. 446

By:

Schiffer, Charles A.

Publication type:

Article

Refractory CML: Not All Forms of Resistance Are Equal.

Published in:

Oncology (08909091), 2008, v. 22, n. 4, p. 437

By:

DeVetten, Marcel

Publication type:

Article

Management of Patients With Resistant or Refractory Chronic Myelogenous Leukemia.

Published in:

Oncology (08909091), 2008, v. 22, n. 4, p. 430

By:

Quintás-Cardama, Alfonso;
Cortes, Jorge

Publication type:

Article

Imatinib Halts Progression to Advanced Stages of Ph-Positive Chronic Myeloid Leukemia in 6th Year of Treatment.

Published in:: Oncology (08909091), 2008, v. 22, n. 1, p. 81
Publication type:: Article

Chronic Myeloid Leukemia: Changing the Treatment Paradigms.

Published in:

Oncology (08909091), 2006, v. 20, n. 14, p. 1850

By:

Savona, Michael;
Talpaz, Moshe

Publication type:

Article

The Savona/Talpaz Article Reviewed.

Published in:

Oncology (08909091), 2006, v. 20, n. 7, p. 719

By:

Roy, Rajasree;
Rai, Kanti R.

Publication type:

Article

The Savona/Talpaz Article Reviewed.

Published in:

Oncology (08909091), 2006, v. 20, n. 7, p. 712

By:

Goldman, John M.

Publication type:

Article

Chronic Myeloid Leukemia: Changing the Treatment Paradigms.

Published in:

Oncology (08909091), 2006, v. 20, n. 7, p. 707

By:

Savona, Michael;
Talpaz, Moshe

Publication type:

Article

Chemotherapy-induced pyoderma gangrenosum.

Published in:

World Council of Enterostomal Therapists Journal, 2019, v. 39, n. 1, p. 9, doi. 10.33235/wcet.39.1.9-17

By:

Wai Kuen Lee, Michelle;
Kar Kay Chan, Steven;
Choi Ching Fong, Amy;
Wai Sze Ho, Kristie

Publication type:

Article

Tyrosine kinase domain mutations in chronic myelogenous leukemia patients: Indian perspective.

Published in:

2022

By:

Ghosh, K

Publication type:

Editorial

DRESS syndrome induced by imatinib.

Published in:

Journal of Postgraduate Medicine, 2021, v. 67, n. 3, p. 158, doi. 10.4103/jpgm.JPGM_746_20

By:

Kaur, S;
Singh, S;
Singh, R;
Singla, P

Publication type:

Article

Development of chronic myelogenous leukemia in a case of chronic lymphocytic leukemia with Tp53 gene deletion.

Published in:

2015

By:

Gupta, A.;
Parihar, M.;
Yadav, A. K.;
Chakrapani, A.

Publication type:

Case Study

Is b3a2 a better prognostic variant in childhood chronic myeloid leukemia?

Published in:

2010

By:

Malhotra, K. P.;
Sharma, C. B.;
Jain, J.;
Grover, R. K.

Publication type:

Case Study

Regenmessung im Mobilfunknetz: Opportunistische Erfassung meteorologischer Größen.

Published in:

Physik in Unserer Zeit, 2021, v. 52, n. 2, p. 88, doi. 10.1002/piuz.202001602

By:

Graf, Maximilian;
Polz, Julius;
Chwala, Christian

Publication type:

Article

ATRA promotes alpha tocopherol succinate-induced apoptosis in freshly isolated leukemic cells from chronic myeloid leukemic patients.

Published in:

Molecular & Cellular Biochemistry, 2008, v. 307, n. 1/2, p. 109

By:

Surender Kumar;
Krishan Khanduja;
Neelam Verma;
Subhash Verma;
Pramod Avti;
Chander Pathak

Publication type:

Article

Identification of common inhibitors of wild-type and T315I mutant of BCR-ABL through the parallel structure-based virtual screening.

Published in:

Journal of Computer-Aided Molecular Design, 2012, v. 26, n. 8, p. 983, doi. 10.1007/s10822-012-9593-7

By:

Park, Hwangseo;
Hong, Seunghee;
Hong, Sungwoo

Publication type:

Article

The Bcr-Abl tyrosine kinase inhibitor imatinib and promising new agents against Philadelphia chromosome-positive leukemias.

Published in:

International Journal of Clinical Oncology, 2007, v. 12, n. 5, p. 327, doi. 10.1007/s10147-007-0699-1

By:

Maekawa, Taira;
Ashihara, Eishi;
Kimura, Shinya

Publication type:

Article

Treatment of chronic myeloid leukemia with imatinib mesylate.

Published in:

International Journal of Clinical Oncology, 2006, v. 11, n. 3, p. 176, doi. 10.1007/s10147-006-0582-5

By:

Ohno, Ryuzo

Publication type:

Article

Stage IVB uterine endometrial cancer successfully salvaged bychemoradiotherapy and surgery.

Published in:

International Journal of Clinical Oncology, 2003, v. 8, n. 1, p. 60, doi. 10.1007/s101470300010

By:

Kaneyasu, Yuko;
Okawa, Tomohiko;
Yajima, Masazumi;
Saito, Rie;
Nakabayashi, Masao;
Seshimo, Akiyoshi;
Kameoka, Shingo;
Aomi, Shigeyuki;
Nishikawa, Toshio;
Sawada, Tatsuo;
Mitsuhashi, Norio

Publication type:

Article

Therapy-related erythroleukemia caused by the administration of UFT and mitomycin C in a patient with colon cancer.

Published in:

International Journal of Clinical Oncology, 2003, v. 8, n. 1, p. 56, doi. 10.1007/s101470300009

By:

Nakamori, Yoshitaka;
Miyazaki, Mutsuko;
Tominaga, Takayuki;
Taguchi, Akihiko;
Shinohara, Kenji

Publication type:

Article

Shoulder pain: a hematologist's perspective.

Published in:

2016

By:

Jain, Ankur;
Malhotra, Pankaj;
Varma, Subhash

Publication type:

Letter

Sustained dasatinib treatment prevents early fibrotic changes following ocular trauma.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 5, p. 1103, doi. 10.1007/s00417-020-05037-4

By:

Ueda, Shunichiro;
Nunn, Betty M.;
Chauhan, Rajat;
McDonald, Kevin;
Kaplan, Henry J.;
O'Toole, Martin G.;
Tamiya, Shigeo

Publication type:

Article

Imatinib pharmacokinetics and creatine kinase levels in chronic myeloid leukemia patients: implications for therapeutic response and monitoring.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 7, p. 1061, doi. 10.1007/s00228-024-03675-9

By:

Omran, Mervat M.;
Ibrahim, Amel B.;
Abdelfattah, Raafat;
Shouman, Samia A.;
Hamza, Marwa S.

Publication type:

Article

Role of ADME gene polymorphisms on imatinib disposition: results from a population pharmacokinetic study in chronic myeloid leukaemia.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 8, p. 1321, doi. 10.1007/s00228-022-03345-8

By:

Shriyan, Bharati;
Mehta, Parsshava;
Patil, Anand;
Jadhav, Shraddha;
Kumar, Sharath;
Puri, Apeksha S.;
Govalkar, Ravina;
Krishnamurthy, Manjunath Nookala;
Punatar, Sachin;
Gokarn, Anant;
Khattry, Navin;
Gota, Vikram

Publication type:

Article

Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinib.

Published in:

European Journal of Clinical Pharmacology, 2020, v. 76, n. 9, p. 1213, doi. 10.1007/s00228-020-02910-3

By:

Boons, Christel C. L. M.;
Timmers, Lonneke;
Janssen, Jeroen J. W. M.;
Westerweel, Peter E.;
Blijlevens, Nicole M. A.;
Smit, Willem M.;
Bartelink, Imke H.;
Wilschut, Janneke A.;
Swart, Eleonora L.;
Hendrikse, N. Harry;
Hugtenburg, Jacqueline G.

Publication type:

Article

Feasibility of and patients' perspective on nilotinib dried blood spot self-sampling.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 6, p. 825, doi. 10.1007/s00228-019-02640-1

By:

Boons, Christel C. L. M.;
Timmers, Lonneke;
Janssen, Jeroen J. W. M.;
Swart, Eleonora L.;
Hugtenburg, Jacqueline G.;
Hendrikse, N. Harry

Publication type:

Article

A clinically relevant pharmacokinetic interaction between cyclosporine and imatinib.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 6, p. 719, doi. 10.1007/s00228-016-2038-9

By:

Atiq, Ferdows;
Broers, Annoek;
Andrews, Louise;
Doorduijn, Jeanette;
Koch, Birgit;
Van Gelder, Teun;
Versmissen, Jorie

Publication type:

Article

Pharmacokinetics and pharmacodynamics of dasatinib in the chronic phase of newly diagnosed chronic myeloid leukemia.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 2, p. 185, doi. 10.1007/s00228-015-1968-y

By:

Ishida, Yoji;
Murai, Kazunori;
Yamaguchi, Kohei;
Miyagishima, Takuto;
Shindo, Motohiro;
Ogawa, Kazuei;
Nagashima, Takahiro;
Sato, Shinji;
Watanabe, Reiko;
Yamamoto, Satoshi;
Hirose, Takayuki;
Saitou, Souich;
Yonezumi, Masakatsu;
Kondo, Takeshi;
Kato, Yuichi;
Mochizuki, Noboru;
Ohno, Keiko;
Kishino, Satoshi;
Kubo, Kohmei;
Oyake, Tatsuo

Publication type:

Article

Nilotinib population pharmacokinetics and exposure-response analysis in patients with imatinib-resistant or -intolerant chronic myeloid leukemia.

Published in:

European Journal of Clinical Pharmacology, 2013, v. 69, n. 4, p. 813, doi. 10.1007/s00228-012-1385-4

By:

Giles, Francis;
Yin, Ophelia;
Sallas, William;
Coutre, Philipp;
Woodman, Richard;
Ottmann, Oliver;
Baccarani, Michele;
Kantarjian, Hagop

Publication type:

Article

Successful pregnancy involving a man with chronic myeloid leukemia on dasatinib.

Published in:

2011

By:

Oweini, Houssam;
Otrock, Zaher;
Mahfouz, Rami;
Bazarbachi, Ali

Publication type:

Letter

Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists.

Published in:

Nature, 2015, v. 525, n. 7569, p. 380, doi. 10.1038/nature15248

By:

Prost, Stéphane;
Relouzat, Francis;
Spentchian, Marc;
Ouzegdouh, Yasmine;
Saliba, Joseph;
Massonnet, Gérald;
Beressi, Jean-Paul;
Verhoeyen, Els;
Raggueneau, Victoria;
Maneglier, Benjamin;
Castaigne, Sylvie;
Chomienne, Christine;
Chrétien, Stany;
Rousselot, Philippe;
Leboulch, Philippe

Publication type:

Article

Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation.

Published in:

Nature, 2015, v. 519, n. 7541, p. 102, doi. 10.1038/nature14119

By:

Pemovska, Tea;
Johnson, Eric;
Kontro, Mika;
Repasky, Gretchen A.;
Chen, Jeffrey;
Wells, Peter;
Cronin, Ciarán N.;
McTigue, Michele;
Kallioniemi, Olli;
Porkka, Kimmo;
Murray, Brion W.;
Wennerberg, Krister

Publication type:

Article

Genetics: Written in blood.

Published in:

Nature, 2013, v. 498, n. 7455, p. S4, doi. 10.1038/498S4a

By:

DeWeerdt, Sarah

Publication type:

Article

Chemical Constituents of Cordyceps neovolkiana DL0004.

Published in:

Chemistry of Natural Compounds, 2021, v. 57, n. 2, p. 392, doi. 10.1007/s10600-021-03369-z

By:

Nguyen, Chi-Dung;
Pham, Thi-My-Ninh;
Ha, Thi-Bich-Hang;
Nguyen, Thi-Phuong;
Nguyen, Huu-Hung;
Phan, Hoang-Vinh-Truong;
Duong, Thuc-Huy;
Dinh, Minh-Hiep

Publication type:

Article

A new sesquiterpene lactone from Hosta ensata.

Published in:

Chemistry of Natural Compounds, 2012, v. 48, n. 4, p. 580, doi. 10.1007/s10600-012-0316-z

By:

Liu, Hong-xin;
Sun, Qian-yun;
Yang, Fu-mei;
Zhao, Fu-wei;
Wang, Yue-hu;
Long, Chun-lin

Publication type:

Article

Design, in silico Evaluation, and Determination of Antitumor Activity of Potential Inhibitors Against Protein Kinases: Application to BCR-ABL Tyrosine Kinase.

Published in:

Biochemistry (00062979), 2024, v. 89, n. 6, p. 1094, doi. 10.1134/S0006297924060099

By:

Koroleva, Elena V.;
Ermolinskaya, Anastasiya L.;
Ignatovich, Zhanna V.;
Kornoushenko, Yury V.;
Panibrat, Alesia V.;
Potkin, Vladimir I.;
Andrianov, Alexander M.

Publication type:

Article

T315I – a gatekeeper point mutation and its impact on the prognosis of chronic myeloid leukemia.

Published in:

Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, 2024, v. 5, n. 4, p. 412, doi. 10.1515/almed-2024-0069

By:

Kaleem, Bushra;
Shahab, Sadaf;
Shamsi, Tahir Sultan

Publication type:

Article

A short review about chronic myeloid leukemia.

Published in:

Journal of Life & Bio-Sciences Research (JLBSR), 2023, v. 4, n. 1, p. 15, doi. 10.38094/jlbsr40172

By:

Al-Bayati, Asmaa M. S.;
Al-Bayti, Ayoub Ali Hussein;
Husain, Vian I.

Publication type:

Article

Comparable Outcomes of Pre-Versus Post-Tyrosine Kinase Inhibitor Era Treatment in Chronic Myeloid Leukemia: A Retrospective Cohort Study With Long-term Follow-up.

Published in:

Cell Transplantation, 2023, v. 32, p. 1, doi. 10.1177/09636897231163212

By:

Tavakoli, Sahar;
Khalaj, Fattaneh;
Kasaeian, Amir;
Mousavi, Seyed Ali;
Mousavian, Amir-Hossein;
Arabi, Fatemeh;
Rad, Soroush;
Rostami, Shahrbano;
Barkhordar, Maryam;
Biglari, Mohammad;
Mardani-Fard, Heydar Ali;
Alemi, Hediyeh;
Khavandgar, Naghmeh;
Kamranzadeh Fumani, Hossein;
Janbabai, Ghasem;
Mousavi, Seied Asadollah;
Ghavamzadeh, Ardeshir;
Vaezi, Mohammad

Publication type:

Article